Journal of Urologic Oncology

Search

Page Path

De Ritis Ratio, Neutrophil-to-Lymphocyte Ratio, and Albumin Are Significant Prognostic Factors for Survival Even After Adjusted by the Treatment Duration in Metastatic Kidney and Bladder Cancer Treated With Immune-Checkpoint Inhibitors: Sung Han Kim, Eun Young Park, Hyung-Ho Lee, Jinsoo Chung, Ho Kyung Seo; Korean J Urol Oncol. 2022;20(1):25-33. Published online February 24, 2022; DOI: https://doi.org/10.22465/kjuo.2022.20.1.25; Full text PubReader ePub PDF

The Correlation of Tissue-Based Biomarkers in Primary and Metastatic Renal Cell Carcinoma Lesions: A Tissue Microarray Study: Sung Han Kim, Weon Seo Park, Eun Young Park, Boram Park, Jungnam Joo, Jae Young Joung, Ho Kyung Seo, Kang Hyun Lee, Jinsoo Chung; Korean J Urol Oncol. 2016;14(3):152-158. Published online December 31, 2016; DOI: https://doi.org/10.22465/kjuo.2016.14.3.152
Cited By 4; Full text PubReader ePub PDF Supplementary Material

Journal of
Urologic Oncology

Print ISSN: 2951-603X
Online ISSN: 2982-7043

MOST READ MOST CITED

6,025	New Drugs for Bacillus Calmette Guérin-Unresponsive Nonmuscle Invasive Bladder Cancer
5,499	The Important Role of Poly ADP-Ribose Polymerase Inhibitor in Prostate Cancer
5,006	An Update of Prostate-Specific Membrane Antigen Theranostics in Prostate Cancer
4,841	Complex Epidemiology of Prostate Cancer in Asian Countries
4,691	The Present and Future of Intravesical Therapy in Bladder Cancer

Cited By 9	Epidemiology of Urologic Cancer in Korea: Nationwide Trends in the Last 2 Decades
Cited By 4	An Update of Prostate-Specific Membrane Antigen Theranostics in Prostate Cancer
Cited By 4	Complex Epidemiology of Prostate Cancer in Asian Countries
Cited By 3	The Evolving Role of Checkpoint Inhibitors in the Treatment of Urothelial Carcinoma: A Literature Review of Practice-Changing Trials
Cited By 2	Prostate Imaging and Reporting and Data System Version 2.1: Limitations for Clinical Use

Editorial Office: Department of Urology, Seoul National University Hospital, Seoul National University College of Medicine,
101 Daehak-ro, Jongno-gu, Seoul 03080, Korea
TEL: +82-2-2072-0817, FAX: +82-2-742-4665 Email: journal@e-juo.org

Korean Urological Oncology Society
50-1 Yonsei-ro, Seodaemun-gu, Seoul 03722, Korea
Tel: +82-2-704-8574, E-mail: kspe.editor@gmail.com